Day One Biopharmaceuticals Inc (NASDAQ:DAWN) currently has a daily average trading volume of 1.37M but it saw 976697 shares traded in last market. With a market cap of 639.59M USD, the company’s current market price of $6.31 came rising about 0.16 while comparing to the previous closing price of $6.30. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.76 and as low as $6.08.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Needham which reiterated the stock as “Buy” in its note to investors issued on October 09, 2024, recommending a price target of between $32 and $33 for it. BofA Securities upgraded its recommendation for the stock as a “Buy” from “Underperform” on August 01, 2024 while assigning a price target range of $11-$24. Needham also issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $30 and $33.
Over the week, DAWN’s stock price is moving -4.10% down while it is -18.48% when we observe its performance for the past one month. Year-to-date it is -50.20% down and over the past year, the stock is showing a downside performance of -54.51%.
Currently, Day One Biopharmaceuticals Inc’s total number of outstanding shares is 101.35M with 17.03% of that held by the insiders while 94.60% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -14.32% and return on equity (ROE) at -17.80%. Stock’s beta reads -1.31. Stock has a price to book (P/B) ratio of 1.33 while price to sale or P/S ratio amounts to 3.95. Its return on asset (ROA) is -16.05% on average.
